[go: up one dir, main page]

BG102222A - Използване на производни на сулфаминовата киселина, ацил сулфонамиди или сулфамоил карбамати за получаването на средство за понижаване на липопротеиновите нива - Google Patents

Използване на производни на сулфаминовата киселина, ацил сулфонамиди или сулфамоил карбамати за получаването на средство за понижаване на липопротеиновите нива

Info

Publication number
BG102222A
BG102222A BG102222A BG10222298A BG102222A BG 102222 A BG102222 A BG 102222A BG 102222 A BG102222 A BG 102222A BG 10222298 A BG10222298 A BG 10222298A BG 102222 A BG102222 A BG 102222A
Authority
BG
Bulgaria
Prior art keywords
sulphamoylcarbamates
acylsulphanomides
medicament
derivatives
preparation
Prior art date
Application number
BG102222A
Other languages
English (en)
Other versions
BG63863B1 (bg
Inventor
Brian KRAUSE
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG102222A publication Critical patent/BG102222A/bg
Publication of BG63863B1 publication Critical patent/BG63863B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до ново терапевтично използване на съединения с формула, в която Х и Y означават кислород, сяра или (CR'R'')n, като n има стойност от 1 до 4, R е водород, алкил или бензил, R1и R2 означават фенил, заместен фенил, нафтил, заместен нафтил, аралкилна група, алкилна верига, адамантил или циклоалкилна група. Тези съединения се използват при цереброваскуларни заболявания, като удар, заболявания на периферната кръвоносна система и растеноза.
BG102222A 1995-08-04 1998-01-30 Използване на производни на сулфаминовата киселина, ацил сулфонамиди или сулфамоил карбамати за получаването на средство за понижаване на липопротеиновите нива BG63863B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (2)

Publication Number Publication Date
BG102222A true BG102222A (bg) 1998-09-30
BG63863B1 BG63863B1 (bg) 2003-04-30

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102222A BG63863B1 (bg) 1995-08-04 1998-01-30 Използване на производни на сулфаминовата киселина, ацил сулфонамиди или сулфамоил карбамати за получаването на средство за понижаване на липопротеиновите нива

Country Status (27)

Country Link
US (1) US6117909A (bg)
EP (1) EP0841913B1 (bg)
JP (1) JPH11510184A (bg)
KR (1) KR19990036127A (bg)
CN (1) CN1192140A (bg)
AT (1) ATE232097T1 (bg)
AU (1) AU716255B2 (bg)
BG (1) BG63863B1 (bg)
CA (1) CA2221729A1 (bg)
CZ (1) CZ26198A3 (bg)
DE (1) DE69626118T2 (bg)
DK (1) DK0841913T3 (bg)
EA (1) EA002435B1 (bg)
EE (1) EE9800037A (bg)
ES (1) ES2191762T3 (bg)
GE (1) GEP20012511B (bg)
HR (1) HRP960341A2 (bg)
HU (1) HUP9900668A3 (bg)
IL (1) IL122247A0 (bg)
NO (1) NO980466D0 (bg)
NZ (1) NZ312571A (bg)
PL (1) PL185943B1 (bg)
PT (1) PT841913E (bg)
SK (1) SK12598A3 (bg)
UA (1) UA46030C2 (bg)
WO (1) WO1997005868A1 (bg)
ZA (1) ZA966617B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
TR200100205T2 (tr) * 1998-07-21 2001-05-21 Warner-Lambert Company Aterosklerotik lezyonların tedavisi için ACAT ve MMP inhibitörlerinin birlikte uygulanması.
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
KR20020050257A (ko) * 1999-11-05 2002-06-26 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Ａｃａｔ 저해제에 의한 플라크 파열의 방지
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
JP7269928B2 (ja) 2017-11-14 2023-05-09 メルク・シャープ・アンド・ドーム・エルエルシー インドールアミン ２，３－ジオキシゲナーゼ（ｉｄｏ）阻害剤としての新規の置換ビアリール化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
ATE116291T1 (de) * 1990-10-30 1995-01-15 Warner Lambert Co Oxysulfonylcarbamate.
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
UA46030C2 (uk) 2002-05-15
EA002435B1 (ru) 2002-04-25
NZ312571A (en) 2000-07-28
IL122247A0 (en) 1998-04-05
DE69626118D1 (de) 2003-03-13
ATE232097T1 (de) 2003-02-15
HRP960341A2 (en) 1998-02-28
KR19990036127A (ko) 1999-05-25
BG63863B1 (bg) 2003-04-30
GEP20012511B (en) 2001-08-27
EA199800176A1 (ru) 1998-10-29
ES2191762T3 (es) 2003-09-16
EE9800037A (et) 1998-08-17
HUP9900668A2 (hu) 1999-06-28
WO1997005868A1 (en) 1997-02-20
JPH11510184A (ja) 1999-09-07
AU716255B2 (en) 2000-02-24
CN1192140A (zh) 1998-09-02
PL324908A1 (en) 1998-06-22
EP0841913B1 (en) 2003-02-05
EP0841913A1 (en) 1998-05-20
SK12598A3 (en) 1999-02-11
DK0841913T3 (da) 2003-05-05
PT841913E (pt) 2003-06-30
PL185943B1 (pl) 2003-09-30
AU6454196A (en) 1997-03-05
HUP9900668A3 (en) 2000-08-28
NO980466L (no) 1998-02-03
ZA966617B (en) 1997-02-18
CA2221729A1 (en) 1997-02-20
CZ26198A3 (cs) 1998-07-15
NO980466D0 (no) 1998-02-03
DE69626118T2 (de) 2003-11-27
US6117909A (en) 2000-09-12

Similar Documents

Publication Publication Date Title
MX9802130A (es) Agonistas adrenergicos beta3 selectivos.
TW349941B (en) Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DK1137762T3 (da) Behandling af Pompes sygdom
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
EP0786995A4 (bg)
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
BG102222A (bg) Използване на производни на сулфаминовата киселина, ацил сулфонамиди или сулфамоил карбамати за получаването на средство за понижаване на липопротеиновите нива
AU8261787A (en) Medicaments for the treatment of depression
IT9041529A1 (it) Dispositivo per la correzione chirurgica dell'ametropia.
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
GB2380939B (en) Treatment or prevention of auto-immune diseases
AU7077096A (en) Selective beta 3 adrenergic agonists
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
IT1244886B (it) Dicarbonati e uretani dell'acido 4,5-diidrossi- e 4,5,8-triidrossi- 9,10-diidro-9,10-diosso-2-antracencarbossilico ad azione terapeutica
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
HUP9901303A2 (hu) Gyógyszerkészítmény autoimmun betegségek kezelésére
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
GB9420747D0 (en) 1,5 benzodiazepine derivatives
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
TR199903054T2 (xx) Yeni pentaerythrit t�revleri, bunlar�n imalat� ve kullan�mlar� ile bunlar�n sentezi i�in ara maddeler.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen